Journals / Türk Kardiyoloji Derneği Arşivi / 2017 / Cilt: 45 - Sayı: 8

Treatment of ineffective endocardial defibrillation with subcutaneous array: a case report

Etkisiz endokardiyal defibrilasyonun subkutan yol ile tedavisi: Olgu sunumu

Pages
748–751
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Presently described is the case of a patient with a high DFT and some of the methods that can be used to manage this circumstance, including the use of a subcutaneous array

📌 3 Key Takeaways

🎯
Objective & Hypothesis:– Defibrillation threshold (DFT) testing is an important part of ICD implantation.
📊
Key Findings & Data:More than 6% of ICDs implanted are not within the DFT safety margin.
💡
Conclusion & Impact:Presently described is the case of a patient with a high DFT and some of the methods that can be used to manage this circumstance, including the use of a subcutaneous array
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

– Defibrillation threshold (DFT) testing is an important part of ICD implantation. After placement of the ICD generator, a DFT test is performed to evaluate the integrity of the ICD system and to confirm a successful defibrillation safety margin. More than 6% of ICDs implanted are not within the DFT safety margin. Presently described is the case of a patient with a high DFT and some of the methods that can be used to manage this circumstance, including the use of a subcutaneous array

Özet

- Defibrilasyon eşik testi (DET) kalp içi defibrilatör (ICD) yerleştirilmesinin önemli bir parçasıdır. Başarılı defib- rilasyonun güvenlik sınırı ve ICD sisteminin tümünü değer- lendirmek için ICD jenaratörü yerleştirildikten sonra DET ya- pılır. ICD'li hastaların %6'dan fazlası DET güvenlik sınırında değildir. Yüksek DET'li hastalarda farklı tedavi yöntemleri kullanılmaktadır. Bu yazımızda yüksek DET'li hastada muh- temel tedavi yöntemi olarak subkutan yol kullanımını tartış- tık

🔖

Cite This Article

KAPLAN, Ö., DEMİRCAN, S. (2022). Treatment of ineffective endocardial defibrillation with subcutaneous array: a case report. Türk Kardiyoloji Derneği Arşivi, Cilt: 45 - Sayı: 8, 748–751. https://ajindex.com/articles/632524

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140–50
  2. Kirilmaz A, Dokumaci B, Uzun M, Kilicaslan F, Dinckal MH, Yucel O, et al. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation. Pacing Clin Electrophysiol 2005;28:498–505
  3. Shorofsky SR, Peters RW, Rashba EJ, Gold MR. Comparison of step-down and binary search algorithms for determination of defibrillation threshold in humans. Pacing Clin Electrophysiol 2004;27:218–20
  4. Mainigi SK, Callans DJ. How to manage the patient with a high defibrillation threshold. Heart Rhythm 2006;3:492–5
  5. Marchlinski FE, Flores B, Miller JM, Gottlieb CD, Hargrove WC 3rd. Relation of the intraoperative defibrillation threshold to successful postoperative defibrillation with an automatic implantable cardioverter defibrillator. Am J Cardiol 1988;62:393–8
  6. Hodgson DM, Olsovsky MR, Shorofsky SR, Daly B, Gold MR. Clinical predictors of defibrillation thresholds with an active pectoral pulse generator lead system. Pacing Clin Electrophysiol 2002;25:408–13
  7. Schuger C, Ellenbogen KA, Faddis M, Knight BP, Yong P, Sample R; VENTAK CHF/CONTAK CD Study Investigators. Defibrillation energy requirements in an ICD population receiving cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2006;17:247–50
  8. Epstein AE, Ellenbogen KA, Kirk KA, Kay GN, Dailey SM, Plumb VJ. Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study. Circulation 1992;86:1206–16
  9. Shukla HH, Flaker GC, Jayam V, Roberts D. High defibrillation thresholds in transvenous biphasic implantable defibrillators: clinical predictors and prognostic implications. Pacing Clin Electrophysiol 2003;26:44–8
  10. Strickberger SA, Klein GJ. Is defibrillation testing required for defibrillator implantation? J Am Coll Cardiol 2004;44:88–91
  11. Healey JS, Hohnloser SH, Glikson M, Neuzner J, Mabo P, Vinolas X, et al. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, noninferiority, randomised controlled trial (SIMPLE). Lancet 2015;385:785–91
  12. Kettering K, Mewis C, Dörnberger V, Vonthein R, Bosch RF, Seipel L, et al. Long-term experience with subcutaneous ICD leads: a comparison among three different types of subcutaneous leads. Pac